111 related articles for article (PubMed ID: 32338233)
1. Differentiating depression and ADHD without depression in adults with processing-speed measures.
Martiny K; Nielsen NP; Wiig EH
Acta Neuropsychiatr; 2020 Oct; 32(5):237-246. PubMed ID: 32338233
[TBL] [Abstract][Full Text] [Related]
2. Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity.
Nielsen NP; Wiig EH; Bäck S; Gustafsson J
Nord J Psychiatry; 2017 May; 71(4):296-303. PubMed ID: 28413936
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study.
Arvidsson M; Dahl ML; Franck J; Wiig EH; Nielsen NP
Nord J Psychiatry; 2019 Feb; 73(2):118-124. PubMed ID: 30861357
[TBL] [Abstract][Full Text] [Related]
4. AQT cognitive speed and processing efficiency differentiate adults with and without ADHD: a preliminary study.
Nielsen NP; Wiig EH
Int J Psychiatry Clin Pract; 2011 Sep; 15(3):219-27. PubMed ID: 22121933
[TBL] [Abstract][Full Text] [Related]
5. Validation of the AQT color-form additive model for screening and monitoring pharmacological treatment of ADHD.
Nielsen NP; Wiig EH
J Atten Disord; 2013 Apr; 17(3):187-93. PubMed ID: 22210798
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.
Hammerness P; Fried R; Petty C; Meller B; Biederman J
Child Neuropsychol; 2014; 20(3):319-27. PubMed ID: 23639146
[TBL] [Abstract][Full Text] [Related]
7. Naming speed performance and stimulant effects indicate effortful, semantic processing deficits in attention-deficit/hyperactivity disorder.
Tannock R; Martinussen R; Frijters J
J Abnorm Child Psychol; 2000 Jun; 28(3):237-52. PubMed ID: 10885682
[TBL] [Abstract][Full Text] [Related]
8. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment.
Low AM; Vangkilde S; le Sommer J; Fagerlund B; Glenthøj B; Jepsen JRM; Bundesen C; Petersen A; Habekost T
Psychol Med; 2019 Nov; 49(15):2617-2625. PubMed ID: 30560740
[TBL] [Abstract][Full Text] [Related]
9. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
[TBL] [Abstract][Full Text] [Related]
10. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.
Biederman J; Seidman LJ; Petty CR; Fried R; Doyle AE; Cohen DR; Kenealy DC; Faraone SV
J Clin Psychiatry; 2008 Jul; 69(7):1150-6. PubMed ID: 18517288
[TBL] [Abstract][Full Text] [Related]
11. Processing speed as a marker to stimulant effect in clinical sample of children with high functioning autism spectrum disorder.
Peled J; Cassuto H; Berger I
Nord J Psychiatry; 2020 Apr; 74(3):163-167. PubMed ID: 31686565
[No Abstract] [Full Text] [Related]
12. Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response and results for parents.
Nigg JT; Swanson JM; Hinshaw SP
Neuropsychologia; 1997 Feb; 35(2):165-76. PubMed ID: 9025120
[TBL] [Abstract][Full Text] [Related]
13. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
Ince Tasdelen B; Karakaya E; Oztop DB
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
[TBL] [Abstract][Full Text] [Related]
14. The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study.
Horowitz I; Avirame K; Naim-Feil J; Rubinson M; Moses E; Gothelf D; Levit-Binnun N
Psychiatry Res; 2020 Sep; 291():113056. PubMed ID: 32554183
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
Wang LJ; Chen CK; Huang YS
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder.
Bedard AC; Ickowicz A; Tannock R
J Child Adolesc Psychopharmacol; 2002; 12(4):301-9. PubMed ID: 12625990
[TBL] [Abstract][Full Text] [Related]
17. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
18. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
19. Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment.
Low AM; le Sommer J; Vangkilde S; Fagerlund B; Glenthøj B; Sonuga-Barke E; Habekost T; Jepsen JRM
Int J Neuropsychopharmacol; 2018 Nov; 21(11):997-1006. PubMed ID: 30124878
[TBL] [Abstract][Full Text] [Related]
20. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
